Cure My Disease

Don't miss your cure!

 Log in / Sign up

Experimental STAR-T cell therapy aims to tame multiple sclerosis

NCT ID NCT07523100

Not yet recruiting Disease control Sponsor: Daishi Tian Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage trial will test the safety of a new immune cell therapy called universal STAR-T cells in 24 adults with multiple sclerosis (MS) who have no other treatment options. The therapy involves infusing specially engineered cells that may help control the disease. The study will first find the safest dose, then expand to confirm safety and look for early signs of effectiveness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Universal STAR-T cell injection (a type of immune cell therapy)
What this could lead to
If this early trial shows the therapy is safe, it could point toward a new way to control multiple sclerosis by targeting the immune system.
What could go wrong
This is a very early Phase 1 study with only 24 participants, so it is too soon to know if it works. There may be serious side effects from the cell therapy, and it is not a cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS (MS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE SCLEROSIS (MS)

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science & Technology

    Wuhan, Hubei, 430030, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.